PELUCCHI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 7.098
AS - Asia 3.218
EU - Europa 3.208
SA - Sud America 586
AF - Africa 55
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.171
Nazione #
US - Stati Uniti d'America 6.942
SG - Singapore 1.320
CN - Cina 867
DE - Germania 558
IT - Italia 495
RU - Federazione Russa 494
BR - Brasile 475
SE - Svezia 407
HK - Hong Kong 398
IE - Irlanda 328
VN - Vietnam 247
UA - Ucraina 226
GB - Regno Unito 209
CA - Canada 122
FI - Finlandia 113
FR - Francia 102
IN - India 79
AT - Austria 65
KR - Corea 50
NL - Olanda 48
TR - Turchia 45
AR - Argentina 40
ID - Indonesia 37
BE - Belgio 33
DK - Danimarca 31
BD - Bangladesh 30
JP - Giappone 28
ZA - Sudafrica 27
IQ - Iraq 24
MX - Messico 23
PL - Polonia 22
ES - Italia 21
EC - Ecuador 20
PK - Pakistan 18
CO - Colombia 16
LT - Lituania 15
VE - Venezuela 14
SA - Arabia Saudita 10
IR - Iran 9
PY - Paraguay 8
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
RO - Romania 6
MA - Marocco 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
AU - Australia 4
BG - Bulgaria 4
EG - Egitto 4
KG - Kirghizistan 4
MY - Malesia 4
PH - Filippine 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
NG - Nigeria 2
OM - Oman 2
SV - El Salvador 2
TW - Taiwan 2
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 14.166
Città #
Ann Arbor 1.285
Singapore 793
Ashburn 683
Woodbridge 556
Fairfield 446
Hong Kong 392
Chandler 388
Houston 388
Frankfurt am Main 343
Dublin 315
Wilmington 256
Jacksonville 236
Dearborn 186
New York 178
Seattle 174
Milan 156
Cambridge 152
Beijing 143
Santa Clara 132
San Jose 116
Los Angeles 113
Princeton 109
Nanjing 95
Hefei 84
Ho Chi Minh City 80
Dallas 79
The Dalles 73
Shanghai 69
Buffalo 58
Vienna 57
São Paulo 52
Lawrence 51
Munich 47
Altamura 45
Seoul 44
Moscow 43
Lachine 40
Hanoi 37
Helsinki 36
Chicago 35
San Diego 35
Brussels 29
Nanchang 28
Turku 27
Dong Ket 26
Jakarta 26
Ottawa 24
Rio de Janeiro 24
Shenyang 24
Boardman 23
Tianjin 22
Guangzhou 21
Orem 21
Turin 21
Council Bluffs 20
Hebei 18
Johannesburg 18
Tokyo 18
Andover 17
Jinan 17
London 17
Poplar 17
Jiaxing 16
Toronto 16
Warsaw 16
Montreal 15
Rome 15
Zhengzhou 15
Changsha 14
Chennai 14
Brooklyn 13
Denver 13
Phoenix 13
Boston 12
Indianapolis 12
Stockholm 12
Campinas 11
Huizen 11
Brasília 10
Nuremberg 10
Pune 10
Quito 10
Atlanta 9
Columbus 9
Curitiba 9
Fremont 9
Mexico City 9
San Francisco 9
Belo Horizonte 8
Desio 8
Düsseldorf 8
Elk Grove Village 8
Hangzhou 8
Kent 8
Kocaeli 8
Mumbai 8
Ningbo 8
Philadelphia 8
Tampa 8
Ankara 7
Totale 9.465
Nome #
Hepcidin regulation in a mouse model of acute hypoxia 542
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 391
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 368
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 336
Hif1a: A putative modifier of hemochromatosis 331
Inherited iron overload disorders 306
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 297
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 291
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 289
Idiopathic erythrocytosis: a germline disease? 285
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 282
Hepcidin regulation in a mouse model of acute hypoxia 279
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 279
Type 3 hemochromatosis and beta-thalassemia trait 275
Circulating factors are involved in hypoxia-induced hepcidin suppression 275
Unexplained isolated hyperferritinemia without iron overload 269
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 264
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 256
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 255
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 245
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 244
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 241
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 240
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 237
Ferroportin disease: A novel SLC40A1 mutation 236
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 234
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 232
Ceruloplasmin variants might have different effects in different iron overload disorders 230
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 224
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 220
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 220
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 217
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 216
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 216
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 215
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 214
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 211
Homozygous deletion of HFE: The Sardinian hemochromatosis? 209
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 206
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 204
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 203
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 202
Total iron-overload measurement in the human liver region by the magnetic iron detector. 191
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 190
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 189
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 185
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 183
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 182
Angiotensin type 2 and mas receptor activation prevents myocardial fibrosis and hypertrophy through the reduction of inflammatory cell infiltration and local sympathetic activity in angiotensin ii‐dependent hypertension 182
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 178
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 178
Erythrocytapheresis plus erythropoietin: An alternative therapy for selected patients with hemochromatosis and severe organ damage 171
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis 165
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 157
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 156
Hypoxia-dependent hepcidin down-regulation: an in vitro study 153
Interaction Between the PNPLA3 I148M Mutation, Body Weight, And Steatosis, In Determining The Progression To Cirrhosis In Hereditary Hemochromatosis 150
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 149
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 139
Hereditary Hyperferritinemia 133
Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis 127
Gene symbol: FTL. Disease: Hyperferritinemia-cataract syndrome 127
Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia 103
Molecular testing in hemochromatosis 85
Emerging nanocarrier systems for the enhanced delivery of active pharmaceutical ingredients to the intestine 30
Totale 14.489
Categoria #
all - tutte 47.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021593 0 0 0 0 0 0 86 71 98 136 84 118
2021/2022960 61 93 106 76 70 56 62 51 40 74 81 190
2022/20231.529 205 429 155 156 101 222 10 84 95 10 30 32
2023/2024982 40 48 43 45 107 272 194 50 42 15 18 108
2024/20252.288 122 193 114 91 238 104 132 110 261 374 220 329
2025/20263.784 721 334 473 749 880 372 255 0 0 0 0 0
Totale 14.489